Kite Lake Capital Management (UK)’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Kite Lake Capital Management (UK)’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-836,070	Closed	-$21.8M	–	12
2019 Q1	$21.8M	Buy	+836,070	New	+$15.6M	6.25%	6

Kite Lake Capital Management (UK)'s CMTA Position: Q2 2019 in Review

Kite Lake Capital Management (UK) sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 836,070 shares — an estimated $21.8M sold.

Kite Lake Capital Management (UK) first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $21.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Kite Lake Capital Management (UK) reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Kite Lake Capital Management (UK) sold 836,070 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $21.8M.
Kite Lake Capital Management (UK) first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
Kite Lake Capital Management (UK)'s Clementia Pharmaceuticals Inc. position peaked at $21.8M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q2 2019, filed 14 Aug 2019.